drugset / Trial / NCT00261248

Vaccine for Recurrent Urinary Tract Infections in Women

NCT00261248 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is determine whether a vaginal mucosal vaccine given to women with a history of recurrent urinary tract infections can reduce the number of infections occurring in a six-month study period, as compared to placebo treatment.

Timeline

Start
1996-11
Primary completion
—
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject inactivated bacteria Vaccine — Other